HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 287/1/H81    most recent 01140.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (15) Citing Articles via Google Scholar Google Scholar Articles by Kido, M. Articles by Imamura, H. Search for Related Content PubMed PubMed Citation Articles by Kido, M. Articles by Imamura, H.

Ischemic preconditioning-mediated restoration of membrane dystrophin during reperfusion correlates with protection against contraction-induced myocardial injury

Departments of ¹Thoracic and Cardiovascular Surgery and ²Cardiology, Kansai Medical University, Moriguchi City 570-8507, Japan

Submitted 2 December 2003 ; accepted in final form 1 March 2004

Dystrophin is an integral membrane protein involved in the stabilization of the sarcolemmal membrane in cardiac muscle. We hypothesized that the loss of membrane dystrophin during ischemia and reperfusion is responsible for contractile force-induced myocardial injury and that cardioprotection afforded by ischemic preconditioning (IPC) is related to the preservation of membrane dystrophin. Isolated and perfused rat hearts were subjected to 30 min of global ischemia, followed by reperfusion with or without the contractile blocker 2,3-butanedione monoxime (BDM). IPC was introduced by three cycles of 5-min ischemia and 5-min reperfusion before the global ischemia. Dystrophin was distributed exclusively in the membrane of myocytes in the normally perfused heart but was redistributed to the myofibril fraction after 30 min of ischemia and was lost from both of these compartments during reperfusion in the presence or absence of BDM. The loss of dystrophin preceded uptake of the membrane-impermeable Evans blue dye by myocytes that occurred after the withdrawal of BDM and was associated with creatine kinase release and the development of contracture. Although IPC did not alter the redistribution of membrane dystrophin induced by 30 min of ischemia, it facilitated the restoration of membrane dystrophin during reperfusion. Also, myocyte necrosis was not observed when BDM was withdrawn after complete restoration of membrane dystrophin. These results demonstrate that IPC-mediated restoration of membrane dystrophin during reperfusion correlates with protection against contractile force-induced myocardial injury and suggest that the cardioprotection conferred by IPC can be enhanced by the temporary blockade of contractile activity until restoration of membrane dystrophin during reperfusion.

reperfusion injury; 2,3-butanedione monoxime

This article has been cited by other articles:

				J. R. Egan, T. L. Butler, A. D. Cole, S. Abraham, J. S. Murala, D. Baines, N. Street, L. Thompson, O. Biecker, J. Dittmer, et al. Myocardial membrane injury in pediatric cardiac surgery: An animal model. J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1154 - 1162. [Abstract] [Full Text] [PDF]

				B. C. Blunt, A. T. Creek, D. C. Henderson, and P. A. Hofmann H2O2 activation of HSP25/27 protects desmin from calpain proteolysis in rat ventricular myocytes Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1518 - H1525. [Abstract] [Full Text] [PDF]

				T. Shojima, N. Hayashida, A. Nishi, K. Takagi, H. Hori, K. Yoshikawa, and S. Aoyagi Effects of nicorandil preconditioning on membrane dystrophin. Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 472 - 479. [Abstract] [Full Text] [PDF]

				S. Kyoi, H. Otani, A. Hamano, S. Matsuhisa, Y. Akita, H. Fujiwara, R. Hattori, H. Imamura, H. Kamihata, and T. Iwasaka Dystrophin is a possible end-target of ischemic preconditioning against cardiomyocyte oncosis during the early phase of reperfusion Cardiovasc Res, May 1, 2006; 70(2): 354 - 363. [Abstract] [Full Text] [PDF]

				N. Maulik Effect of p38 MAP kinase on cellular events during ischemia and reperfusion: possible therapy Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2302 - H2303. [Full Text] [PDF]

				T. Okada, H. Otani, Y. Wu, S. Kyoi, C. Enoki, H. Fujiwara, T. Sumida, R. Hattori, and H. Imamura Role of F-actin organization in p38 MAP kinase-mediated apoptosis and necrosis in neonatal rat cardiomyocytes subjected to simulated ischemia and reoxygenation Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2310 - H2318. [Abstract] [Full Text] [PDF]

				T. Sumida, H. Otani, S. Kyoi, T. Okada, H. Fujiwara, Y. Nakao, M. Kido, and H. Imamura Temporary blockade of contractility during reperfusion elicits a cardioprotective effect of the p38 MAP kinase inhibitor SB-203580 Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2726 - H2734. [Abstract] [Full Text] [PDF]